Comparison of the Efficacy of Mesotherapy and Extracorporeal Shock Wave Therapy in Patients With Lateral Epicondylitis
Launched by HAYDARPASA NUMUNE TRAINING AND RESEARCH HOSPITAL · Jun 20, 2025
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying two different treatments for tennis elbow, a condition that causes pain on the outside of the elbow. Researchers want to see how well mesotherapy—a treatment where small doses of medicine are injected into the skin—works compared to extracorporeal shock wave therapy (ESWT), which uses sound waves to help heal the affected area. The goal is to find out if mesotherapy is as effective as ESWT in reducing pain and improving function.
If you are between 18 and 65 years old, have had pain and tenderness on one elbow for at least six weeks, and have been diagnosed with tennis elbow, you might be eligible to join. People who have had recent elbow injections, physical therapy, or certain health conditions may not qualify. Participants will be randomly assigned to receive either five weekly mesotherapy sessions or five weekly ESWT sessions. Your progress will be checked before treatment, shortly after the last session, and again 12 weeks later to see how well the treatments worked. This study is currently looking for volunteers and aims to help find better ways to treat tennis elbow.
Gender
ALL
Eligibility criteria
- • Inclusion Criteria
- • Aged between 18 and 65 years
- • Pain and tenderness in the unilateral lateral epicondyle for ≥6 weeks
- • Clinically diagnosed with Lateral Epicondylitis
- • Patients without cognitive deficits who can follow verbal instructions Exclusion Criteria
- • Receiving an interventional injection in the elbow region within the last 3 months
- • Receiving physical therapy in the last 3 months
- • Receiving regular nonsteroidal anti-inflammatory drug (NSAID) treatment in the last 2 weeks
- • History of fracture or surgery in the affected elbow region
- • Chronic inflammatory diseases
- • Acute infection
- • History of malignancy
- • Coagulation disorders
- • Pregnancy
- • Presence of a pacemaker or electronic implants
- • Cervical radiculopathy and entrapment neuropathy
- • Drug allergies
- • BMI \> 35
About Haydarpasa Numune Training And Research Hospital
Haydarpasa Numune Training and Research Hospital is a leading healthcare institution located in Istanbul, Turkey, dedicated to advancing medical knowledge and patient care through innovative clinical research. As a prominent sponsor of clinical trials, the hospital integrates cutting-edge research methodologies with comprehensive training programs, fostering a collaborative environment for healthcare professionals. With a commitment to ethical standards and patient safety, Haydarpasa Numune Hospital aims to contribute significantly to the scientific community by facilitating studies that address critical health challenges and improve therapeutic outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Istanbul, , Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported